Legend Biotech Corp ADR (NASDAQ: LEGN) is -31.94% lower on its value in year-to-date trading and has touched a low of $38.60 and a high of $70.13 in the current 52-week trading range. The question becomes, what are the chances the stock will make a comeback and enjoy potential growth. Why not look at analysts view on what the future holds for the stock. The LEGN stock was last observed hovering at around $41.39 in the last trading session, with the day’s loss setting it -0.44%.
Currently trading at $40.95, the stock is -8.06% and -14.48% below its SMA20 and SMA50 respectively. However, with a daily trading volume of 1.89 million and changing -1.06% at the moment leaves the stock -20.78% off its SMA200. LEGN registered -38.42% loss for a year compared to 6-month gain of -10.04%. The firm has a 50-day simple moving average (SMA 50) of $48.1965 and a 200-day simple moving average (SMA200) of $51.784824.
The stock witnessed a -16.15% loss in the last 1 month and extending the period to 3 months gives it a -26.74%, and is -9.04% down over the last 5 days. If we measure the stock’s price variations over the week and the month, we find that the volatility rates stand at 6.88% over the week and 5.31% over the month.
Legend Biotech Corp ADR (LEGN) has around 1826 employees, a market worth around $7.50B and $455.99M in sales. Profit margin for the company is -62.50%. Distance from 52-week low is 6.09% and -41.61% from its 52-week high. The company has generated returns on investments over the last 12 months (-19.07%).
The EPS is expected to grow by 39.33% this year
The shares outstanding are 181.91M, and float is at 181.45M with Short Float at 6.59%.
The top institutional shareholder in the company is FMR LLC with over 17.62 million shares valued at $780.46 million. The investor’s holdings represent 9.6819 of the LEGN Shares outstanding. As of 2024-06-30, the second largest holder is PRICE T ROWE ASSOCIATES INC /MD/ with 11.49 million shares valued at $508.86 million to account for 6.3126 of the shares outstanding. The other top investors are RA CAPITAL MANAGEMENT, L.P. which holds 7.51 million shares representing 4.1246 and valued at over $332.48 million, while HHLR ADVISORS, LTD. holds 3.6463 of the shares totaling 6.64 million with a market value of $293.93 million.
Legend Biotech Corp ADR (LEGN) Insider Activity
Still, SEC filings show that on Sep 20 ’24, Yau Wai Man Philip (Director) Proposed Sale 1,946 shares at an average price of $51.04 for $99324.0. The insider now directly holds shares of Legend Biotech Corp ADR (LEGN).
